United States: Securities Litigation Alert: District Court Says Indirect Purchasers Of Shares Can Bring Fraud Claims Against Private Company And Its Officers

In a case with important implications for late-stage private companies, a federal magistrate judge ruled last week that investors in funds holding private company securities can bring fraud claims against the issuer of the securities and its officers, even though the plaintiffs had no dealings with the issuer or its officers and hold no actual shares. 

The dispute involves the securities of Theranos, a private life sciences company headquartered in Silicon Valley. In Colman v. Theranos, a case of first impression, U.S. Magistrate Judge Nathanael Cousins of the Northern District of California held that California Corporations Code sections 25400(d) and 25500 permit suits by "indirect purchasers" of pre-IPO shares, i.e. purchasers who bought securities interests from intermediaries and not from the issuer. In its April 18 decision, the court reasoned that because the statutes are designed to combat fraud affecting the market and price for the issuer's securities, there is no requirement that a purchaser have direct dealings with the issuer, or even that the purchaser have relied specifically on any alleged false statement made by the issuer. Instead, the court held, false public statements which are alleged to have affected the market for the issuer's securities, and which the issuer made to induce purchase of the company's shares generally, can form the basis for a claim under California law. The court further held that plaintiffs may sue corporate officers responsible for the allegedly false statements.

Not only is the dramatic expansion of liability to indirect purchasers noteworthy, but also striking is the court's finding that Theranos' consumer-facing advertising and publicity about its products and company prospects can form the basis for a securities fraud claim. The court accepted without challenge the plaintiffs' assertion that Theranos' "advertising campaign [about the company's product] was for the purpose of raising capital." In essence, at least at this stage of the proceedings, the court accepted the plaintiffs' argument that the defendants pushed a false public "story" about Theranos to increase the valuation of the company's securities, which would benefit Theranos.     

Lawsuit Comes Amid Increased Attention to Sales of Pre-IPO Shares

The plaintiffs in the case did not invest directly in Theranos securities. Instead, they invested through funds created by intermediaries for the sole purpose of purchasing Theranos securities. One plaintiff purchased "member interests" in a fund set up to purchase Theranos shares. The other plaintiff purchased "Series B units" issued by a fund allegedly set up to acquire and hold Theranos securities obtained from current and former Theranos investors and personnel.  Neither fund was affiliated with Theranos.

Beginning in 2015, Theranos increasingly came under fire after a series of media articles challenged the efficacy of the company's technology. In 2016, two plaintiffs filed a putative class action on behalf of anyone who directly or indirectly purchased or committed to purchase "an interest in Theranos securities." The plaintiffs claim that the value of their securities interests are now nearly worthless as a result of the defendants' alleged fraud. The suit alleges fraud, unfair competition and violations of California's securities laws and names as defendants Theranos, its founder/CEO Elizabeth Holmes, and its former chief operating officer Ramesh Balwani. 

The lawsuit follows in the wake of increased attention to platforms that offer to broker sales of pre-IPO shares, or offer interests in funds that hold such pre-IPO shares. We previously have discussed this phenomenon in a 2016 client alert, " The SEC's Silicon Valley Initiative: What You Need to Know About the SEC's Increasing Scrutiny of Private Companies and Secondary Market Trading in Pre-IPO Shares." 

Court Allows Majority of Claims Under Common Law and California's Unfair Competition Law

The court held that the plaintiffs could pursue claims against Theranos and its officers under California Corporations Code sections 25400(d) and 25500.1 The court's holding emphasized the statute's broad purpose in preventing sellers of securities from manipulating the market through fraud. The court noted that the statute does not require any relationship between the seller and the buyer, or require that a plaintiff demonstrate reliance on the alleged misrepresentations. It also noted the absence of any persuasive authority limiting liability to the corporate issuer. Thus, the court found that the plaintiffs could pursue claims against Theranos and its officers even though there was admittedly no privity, or other direct relationship, between plaintiffs and defendants.

The court further held that the complaint's listing of allegedly false public statements about the company's products, including consumer-facing advertising, could form the basis of the false statements giving rise to securities fraud claims.  The complaint cited specific newspaper articles, interviews and other statements that were part of Theranos' advertising campaign touting its technology, and alleged that the plaintiffs relied upon the statements before purchasing interests in Theranos securities through the relevant third-party funds. The court held that the allegations were reasonably specific, demonstrated justifiable reliance, and stated a plausible claim for fraud.

The court further held that the plaintiffs could pursue common law claims against Theranos and its officers. However, the court did grant the defendants' motion to dismiss claims brought under California Corporations Code sections 25401 and 25501.2 The court held that those statutes expressly require privity between plaintiffs and defendants, which the plaintiffs failed to allege.

Finally, the court found that the intermediaries who sold the fund interests to the plaintiffs, including on-line private securities broker SharesPost Financial Corporation, may be required to be joined as defendants because they may be essential parties. Because joining the additional parties could affect the plaintiffs' chosen venue, the court ordered further briefing on this point. 

Practical Considerations for Private Companies

To reduce potential exposure to similar indirect purchaser claims, private companies should consider doing the following:

  • When making public statements about the company and its products, private companies should be careful to not overly hype future prospects, and should use cautionary language where appropriate. Companies should be particularly cautious when discussing the valuation of its securities.   
  • Companies should ensure that its securities expressly reflect any restrictions on transfer. They should further notify intermediaries brokering or selling interests in the company's securities of any transfer restrictions and consider publicizing the restrictions on the company's website or through other means.
  • To the extent a private company seeks to prevent or limit public secondary market sales of its securities, it should put intermediaries and potential securities purchasers on notice that the company does not sanction such sales, and that transfer restrictions may make any sales null and void.  Further, companies should direct intermediaries to make potential purchasers aware of the transfer restrictions and that the company disclaims all liability to purchasers, including indirect purchasers of fund interests. 
  • Companies should consider making periodic disclosures on their website or through other public means noting that the company's securities are not registered, and that any advertisement campaign by the company is not intended to be used in connection with the offer, sale or purchase of the company's securities.

Decision May Be the First of Many in this Emerging Area

The recent emergence of public trading in the securities of private, unlisted companies is creating new questions about the reach of liability when aggrieved security holders and aggressive plaintiffs' law firms seek redress for losses.  Private companies that have chosen to not publicly list their securities or to facilitate secondary market trading in their stock no doubt will find last week's decision both puzzling and distressing. But while Magistrate Judge Cousins' decision last week certainly is an important first decision in the emerging legal landscape in this area, it is just that—a first decision, and one made on a motion to dismiss without a fully developed record. Other courts may well reject the expansive view of the California securities laws offered by the court. In the meantime, private issuers can and should take steps to mitigate potential future exposure to similar suits from indirect purchasers.

Footnotes

1 Section 25400(d) prohibits broker-dealer[s] and "other person[s] selling or offering for sale or purchasing or offering to purchase the security" from making false or misleading statements "for the purpose of inducing the purchase or sale of such security by others." Section 25500, in turn, imposes civil liability on "any person who willfully participates in any act or transaction in violation of Section 25400." 

2 Section 25401 prohibits the use of false or misleading statements in connection with security transactions within the state of California.  Section 25501, in turn, provides that "[a]ny person who violates Section 25401 shall be liable to the person who purchases a security from him or sells a security to him." 

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Events from this Firm
25 Sep 2018, Conference, California, United States

We're excited to introduce Women's IP Strategy, a 2-day conference that tackles both the IP, legal as well as broader career development obstacles, risks and rewards for women lawyers working in male-dominant industries.

2 Oct 2018, Webinar, California, United States

This CLE webinar will offer suggestions to litigators to help them comply with the new GDPR during e-discovery.

10 Oct 2018, Webinar, California, United States

For the past years, 3D printing has significantly revolutionized the business industry as it provides innovations and improvement to pre-existing processes.

Similar Articles
Relevancy Powered by MondaqAI
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions